Conifer Point Pharmaceuticals, LLC
Publicly observedDoylestown, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Doylestown | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Conifer Point Pharmaceuticals, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | RFUJM8H9JSU4 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant1 Jun 2016Publicly observed
NIH SBIR/STTR award: An Open Web Service For Fragment-based Design of Small Molecule Inhibitors
USD 1,000,000.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
- Grant1 Jun 2016Publicly observed
NIH SBIR/STTR award: An Open Web Service For Fragment-based Design of Small Molecule Inhibitors
USD 1,050,000.00 · National Institute of General Medical Sciences · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.